Pharmacy Home Adherence Reporting and Monitoring Outcomes Study

NCT02306122 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2697

Last updated 2022-01-11

Study results available
· View outcomes & findings →

Summary

This study is a pilot test of an intervention that delivers timely diagnostic information about medication nonadherence to doctors, and then offers the services of clinical pharmacists to treat these nonadherence problems. Participating doctors will be notified when a patient is 10 days late refilling a medication for diabetes, hypertension, or hypercholesterolemia. In one randomization arm the pharmacist will contact the patient as the default option (with no action required by the doctor), and in the other the pharmacist will contact the patient only if the doctor actively chooses that the pharmacist take action. Patients of participating doctors will be randomized to 1) one of these two pharmacist options, 2) an information only control arm in which the doctor gets adherence information but does not have access to a pharmacist for that patient, and 3) a no information control arm. The investigators' central hypothesis is that the pharmacist will be consulted more often when intervention by the pharmacist is the default outcome and that the default pharmacist intervention will be the most beneficial for adherence outcomes.

Conditions

Interventions

BEHAVIORAL

Pharmacist calls patient unless physician cancels call

BEHAVIORAL

Patient nonadherence information sent to physician

BEHAVIORAL

Pharmacist calls patient if physician requests call

BEHAVIORAL

Doctor receives information and may be allowed certain actions

Sponsors & Collaborators

Principal Investigators

  • Ira B Wilson, MD, MSc · Brown University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02306122 on ClinicalTrials.gov